For most of its history, non-invasive prenatal testing has focused on a small set of common chromosomal conditions - trisomies 21, 18, and 13, along with sex chromosome aneuploidies. These conditions were the low-hanging fruit: they involve whole or large chromosomal changes that are relatively straightforward to detect from cell-free